Pathogens | All VAT patients (N = 34) | VAT did not progressed to VAP (N = 27) | VAT progressed to VAP (N = 7) |
Gram-Positive Cocci Methicillin-resistant Staphylococcus aureus | 13 (38%) | 12 (44%) | 1 (14%) |
Methicillin-sensitive Staphylococcus aureus | 6 (18%) | 2 (7%) | 4 (57%) |
Enterococcus species | 2 (6%) | 2 (7%) | 0 |
Gram-Negative Pathogens Psudomonas aeruginosa | 3 (9%) | 2 (7%) | 1 (14%) |
Escherichia coli | 2 (6%) | 1 (4%) | 1 (14%) |
Klebsiella pneumoniae | 5 (15%) | 4 (15%) | 1 (14%) |
Klebsiella oxytoca | 1 (3%) | 0 | 1 (14%) |
Enterobacter species | 1(3%) | 1 (4%) | 0 |
Serratia marcescens | 2 (6%) | 2 (7%) | 0 |
Proteus mirabilis | 1 (3%) | 1 (4%) | 0 |
Stenotrophomonas maltophilia | 2 (6%) | 1 (4%) | 1 (14%) |
Acinectobacter baumannii | 1 (3%) | 1 (4%) | 0 |
Chryseobacterium species | 1 (3%) | 1 (4%) | 0 |
Haemophilus influenza | 2 (6%) | 1 (4%) | 1 (14%) |
One Pathogen | 27 (79%) | 23 (86%) | 4 (57%) |
Two Pathogens | 4 (12%) | 2 (7%) | 2 (29%) |
Three Pathogens | 3 (9%) | 2 (7%) | 1 (14%) |